期刊文献+

Aβ_(1-42)寡聚体诱导的AD模型大鼠行为学观察与NALP1/Caspase-1表达分析 被引量:2

Observation of praxiology and analysis of NALP1/Caspase-1 expression in AD model rat induced by Aβ_(1- 42) oligomers
在线阅读 下载PDF
导出
摘要 目的研究Aβ1-42寡聚体诱导的阿尔茨海默病(AD)模型大鼠认知功能损害,NALP1、细胞凋亡蛋白酶-1(Caspase-1)在AD模型大鼠大脑皮质和海马的表达。方法将Morris水迷宫初筛后的60只大鼠随机均分为:D-半乳糖组、Aβ1-42纤维组、Aβ1-42寡聚体组、假手术组。分别以Aβ1-42纤维和Aβ1-42寡聚体双侧海马注射建立AD大鼠模型,D-半乳糖组腹腔注射D-半乳糖,假手术组海马注射等量生理盐水。经Morris水迷宫检测其行为学变化,采用免疫组化法、RT-PCR法观察NALP1、Caspase-1在大鼠海马的表达。结果与假手术组相比,其余3组大鼠学习记忆能力明显下降(P<0.05),以Aβ1-42寡聚体组最明显;免疫组化法显示Aβ1-42寡聚体组海马Caspase-1免疫反应阳性神经元数目显著增加,RT-PCR法显示与Aβ1-42纤维组、D-半乳糖组和假手术组比较,Aβ1-42寡聚体组海马Caspase-1和NALP1 mRNA表达增强,差异有统计学意义(P<0.05)。结论 Aβ1-42寡聚体海马注射可导致大鼠认知功能障碍,上调NALP1及Caspase1表达。NALP1及Caspase1可能在Aβ1-42寡聚体介导的大鼠认知功能障碍起重要作用,其作用机制有待进一步研究。 Objective To explore the change of cognition and NALP 1 ( NACHT-LRR-PYD containing protein 1 )/ Caspase-I expression of hippocampus in AD model, we develop Alzheimer's disease (AD) rat model induced by Aβ1-42 oligomers. Methods 60 rats screened by Morris water maze were randomly divided into four groups: D-galactose group, Aβ1-42fiber group, Aβ1-42 oligomers group, Sham-operated group. AD rat models were established by injection bilaterally with Aβ1-42 oligomers or Aβ1-42 fibers into bilateral hippocampus respectively with the stereotaxic apparatus, intraperitoneal injection of D-gal was performed in D-galactose group, in sham-operated group bilateral hippocampus were injected with saline solution. Their behavior changes were detected by Morris water maze, immunohistochemisty, RT-PCR analysis were performed to investigate NALP1/Caspase-1 expression of hippocampus in rat models. Results Compared with Sham-operated group, learning and memory abilities were decreased significantly(P 〈 0.05 )in the other group, especially in Aβ1-42 oligomers model. Immunohistochemistry assay showed that the number and density of Caspase-1 immune-positive neurnons were increased in hippocampus of Aβ1-42 oligomers rat model. RT-PCR analysis showed that the level of Caspase-1 and NALP1 mRNA expression was significantly enhanced in the hippocampus of Aβ1-42 oligomers model and the differences were statistically significant (P 〈 0.05 ). Conclusion Aβ1-42 oligomers injected into hippocampus lead to cognitive dysfunction in AD rat model, which can upregulate NALP1 and Caspase-1 expression. NALP1 and Caspase-1 may play an important role in the Aβ1-42 oligomers-mediated cognitive dysfunction, and its mechanism wait to be further investigated.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第12期1453-1457,共5页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81260174) 广西自然科学基金资助项目(编号:0499017)
关键词 Aβ1-42纤维 Aβ1-42寡聚体 AD NALP1 Casepase-1 Aβ1-42 fibers Aβ1-42 oligomers AD NALP1 Caspase-1
作者简介 孙婧霞,女,硕士研究生; 蒋常文,男,教授,硕士生导师,责任作者,E-mail:jiangchangwen_gl@163.com
  • 相关文献

参考文献11

  • 1Tanzi R E,Moir R D,Wagner S L,et al.Alzheimers abeis peptidethem any roads to perdition[J].Neuron,2004,43(5):605-8.
  • 2刘春喜,黄耀德.阿尔茨海默病中β淀粉样蛋白的神经毒作用[J].上海第二医科大学学报,2004,24(6):483-486. 被引量:9
  • 3George Paxinos,Charles Watson.The rat brain in stereotaxiccoodinate fourth edition [M].Orlando Florida:Academic Press,1998:80-9.
  • 4Alp6r A,Ueberham U,Briickner M K,et al.Different dendriteand dendritic spine alterations in basal and apical arborr ii mutanthuman amyloid precursor protein transgenic mice [J].Brain Res,2006,1099(1):189-98.
  • 5Westerman M A,Cooper-Blacketer D,Mariash A,et al.The rela-tionship between A[3 and memory ii the Tg 2576 mouse model ofAlzheimer's disease[J].Neurosci,2002,22(5):1858-67.
  • 6Haass C,Selkoe D J.Soluble protein oligomers ii neurodegenera-tion:lessons from the Alzheimer's amyloid beta-peptide [J].NatRev Mol Cell Biol,2007,8(2):101-12.
  • 7Ferreira S T,Vieira M N,De Felice F G.Soluble protein oli-gomers as emerging toxins in Alzheimers and other amyloid disea-ses[J].IUBMB Life,2007,59(4/5):332-45.
  • 8Glabe C C.Amyloid accumulatio and pathogensis of Alzheimer'sdisease:significance of monomeric,oligomeric and fibrillar Abeta[J].Subcell Biochem,2005,38:167-77.
  • 9De Felice F G,Vieira M N,Saraiva L M,et al.Targeting theneurotoxic species in Alzheimer ' s disease:inhibitors of Abeta oli-gomerization[J].FASEB,2004,18(12):1366-72.
  • 10Cleary J P,Walsh D M,Hofmeister J J.Natural oligomers of theamyloid-beta protein specifically disrupt cognitive function [J].Nat Neurosci,2005,8(1):79-84.

二级参考文献25

  • 1[1]Selkoe DJ. Deciphering the genesis and fate of amyloid beta protein yields novel therapies for Alzheimer disease[J]. J Clin Invest, 2002,110(10),1 375-1 381.
  • 2[2]Weller RO, Massey A, Kuo YM, et al. Cerebrovascular disease is a major factor in the failure of elimination of Abeta from the aging human brain: implications for therapy of Alzheimer's disease[J]. Ann NY Acad Sci, 2002,977,162-168.
  • 3[3]Carpentier M, Robitaille Y, DesGroseillers L, et al. Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy[J]. J Neuropathol Exp Neurol, 2002,61(10): 849-856.
  • 4[4]Hashimoto Y, Niikura T, Ito Y, et al. Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein[J]. J Biol Chem, 2000,257(44): 34 541-34 551.
  • 5[5]Moechars D, Lorent K, Van Leuven F. Premature death in transgenics mice that overexpress a mutant amyloid precursor protein is preceded by severe neurodegeneration and apopotosis[J]. Neuroscience, 1999,91(3): 819-830.
  • 6[6]Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy[J]. Physiol Rev, 2001,81(2): 741-766.
  • 7[7]Soto C, Kindy MS, Baumann M, et al. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta sheet conformation[J]. Biochem Biophys Res Commun, 1996,226(3): 672-680.
  • 8[8]Bush AI, Tanzi RE. The galvanization of beta amyloid in Alzheimer's disease[J]. Proc Natl Acad Sci USA, 2002,99(11): 7 317-7 319.
  • 9[9]Walsh DM, Klyubin I, Fadeeva JV, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long term potentiation in vivo[J]. Nature, 2002,416(6880): 535-539.
  • 10[10]Kayed R, Head E, Thompson JL, et al.Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis[J]. Science, 2003,300: 486-489.

共引文献8

同被引文献21

  • 1冯荣芳,冯亚青,吕佩源.阿尔茨海默病动物模型研究进展[J].脑与神经疾病杂志,2008,16(6):724-726. 被引量:17
  • 2罗磊,杜艳军,孙国杰.Aβ1~40、Aβ1~42与Aβ25~35在阿尔茨海默病模型复制中的评价[J].中国老年学杂志,2014,34(9):2584-2586. 被引量:14
  • 3蔡志友,晏勇.阿尔茨海默病转基因动物模型研究[J].重庆医学,2007,36(21):2221-2223. 被引量:2
  • 4Crews L,Masliah E.Molecular mechanisms of neurodegeneration in Alzheimer's disease[J].Hum Mol Genet,2010,19(R1):R12-20.
  • 5Yu L,Edalji R,Harlan JE,et al.Structural characterization of a soluble amyloidβ-peptide oligomer[J].Biochemistry,2009,48(9):1870-1877.
  • 6Haass C,Selkoe DJ.Soluble protein oligomers in neurodegeneration:lessons from the Alzheimer's amyloid beta-peptide[J].Nat Rev Mol Cell Boil,2007,8(2):101-112.
  • 7Ferreira ST,Vieira MN,De Felice FG.Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases[J].IUBMB Life,2007,59(4/5):332-345.
  • 8Allaman I,Gavillet M,Bélanger M,et al.Amyloid-βaggregates cause alterations of astrocytic metabolic phenotype:Impact on neuronal viability[J].J Neurosic,2010,30(9):3326-3338.
  • 9Hardy J,Selkoe DJ.The amyloid hypothesis of Alzheimers's disease:progress and problems on the road to therapeuties[J].Science,2002,297(5580):353-356.
  • 10Glabe CG.Common mechanisms of amyloid oligomer pathogenesis in degenerative disease[J].Neurobiol Aging,2006,27(4):570-575.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部